Fig. 3From: Comparison between immunotherapy efficacy in early non-small cell lung cancer and advanced non-small cell lung cancer: a systematic reviewForest plots presenting with pooled DCR risk ratio analysis in early-stage lung cancer and DCR risk ratio analysis for the cohort of immunotherapy alone and immunotherapy combined with other therapiesBack to article page